Showing results (651-660 of 1,324) with videos related to
Sort By:
Pageof 133
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 30, 2018
Frequency of use and perceived helpfulness of wellness strategies for bipolar and unipolar depressionJoshua D Rosenblat, Gregory E Simon, Gary S Sachs, et al.Journal of Strength and Conditioning Research|December 14, 2007
Effect of torso rotational strength on angular hip, angular shoulder, and linear bat velocities of high school baseball playersDavid J Szymanski, Joseph S McIntyre, Jessica M Szymanski, et al.Schizophrenia Research. Cognition|March 24, 2025
Effect of cariprazine on attention and quality of life in patients with predominant negative symptoms of schizophrenia: A post-hoc analysisOloruntoba J Oluboka, Andrea Bardell, Howard C Margolese, et al.Journal of Psychiatric Research|February 16, 2025
The effect of glucagon-like Peptide-1 receptor agonists on measures of suicidality: A systematic reviewKyle Valentino, Kayla M Teopiz, William Cheung, et al.Journal of Affective Disorders|September 22, 2018
Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depressionJoshua D Rosenblat, Gregory E Simon, Gary S Sachs, et al.Bipolar Disorders|October 31, 2012
A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorderRoger S McIntyre, Joanna K Soczynska, Hanna O Woldeyohannes, et al.The Journal of Clinical Psychiatry|October 6, 2007
Substance use disorders and overweight/obesity in bipolar I disorder: preliminary evidence for competing addictionsRoger S McIntyre, Susan L McElroy, Jakub Z Konarski, et al.Journal of Psychopharmacology (Oxford, England)|March 13, 2024
Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depressionNelson B Rodrigues, David Chen-Li, Joshua D Di Vincenzo, et al.Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 28, 2017
Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week StudyYoung Sup Woo, Roger S McIntyre, Jung-Bum Kim, et al.CNS Drugs|August 21, 2015
The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorderRoger S McIntyre, Holly X Xiao, Kahlood Syeda, et al.Pageof 133